维普期刊资源整合服务平台（V6.5）

44篇 您的检索式：作者名="Gershtein"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Vascular endothelial growth factor and its type 2 receptor in tumors and serum of patients with renal cancer显示文摘	N. E. Kushlinsky M. F. Trapeznikova E. S. Gershtein P. A. Glibin I. A. Kazantceva M. B. Kilichbekov	2008	Bulletin of Experimental Biology and Medicine2008，，6：	1
2	Phosphatidy linositol3kinase/AKT signaling pathway components in human breast cancer:clinicopathological correlations显示文摘	Gershtein ES Scherbakov AM: Shatshkaya VA	2007	Anficancer Res2007，27，4：	1
3	Soluble fragment of HER2/neu receptor in the serum of patients with breast cancer with different levels of this protein expression in the tumor 显示文摘	Kushlinskii NE Shirokii VP Gershtein ES	2007	Bull Exp Biol Med2007，143，4：	1
4	Urokinase and tissue plasminogen activators and their inhibitor PAl - 1 in human tumors 显示文摘	Gershtein ES Kushlinskii NE	2001	BullExp Biol Med2001，131，1：	1
5	Expres- sion of VEGF and VEGFR2 in tumors during neoadjuvant therapy of patients with breast cancer显示文摘	Kim EA Gershtein ES Vysotskaya IV	2008	Bull Exp Biol Med2008，145，2：	1
6	Clinical prospects of tumor-associated proteases and their tissue inhibitors investigation in oncologic patient显示文摘	GERSHTEIN ES KUSHINSKII NE	2013	Vestn RossAkad Med Nauk2013，12，5：	1
7	Matrix metalloproteinases 2,7,and 9 in tumors and sera of patients with breast cancer显示文摘	Katunina AI Gershtein ES Ermilova VD	2011	Bull Exp Biol Med2011，151，3：	1
8	Phosphatidylinositol 3-kinase/AKT signalling pathway components in human breast cancer:clinicopathological correlations显示文摘	Scherbakov AM Shatskaya VA	2007	Anticancer Res2007，27，4：	1
9	CyTopolasmic receptors of steroid hormones and clinical - morphological characteristics of skin melanoma 显示文摘	Gershtein ES Tailakov BB Smimva KD	1991	Vopr Onkol1991，37，4：	1
10	Urokinase and tissue plasminogen aetivators and their inhibitor PAI-1 in human tumors 显示文摘	Gershtein ES Kushlinskii NE	2001	Bull Exp Biol Med2001，131，1：	1
11	Matrix metalloproteinases 7 and 9 and their types 1 and 4 tissue inhibitors in tumors and plasma of patients with colorectal cancer显示文摘	Gershtein ES Korotkova EA Shcherbakov AM	2007	Bull Exp Biol Med2007，143，4：	1
12	Plasminogen activators and their inhibitor in bone tumors and tumor-like damages 显示文摘	Kushlinskii NE Yusifov AI Gershtein ES	2001	Bull Exp Biol Med2001，132，2：	1
13	Treatment of multiple sclerosis with copolymer-1 (Copaxone):implicating mechanisms of Th1 to Th2/Th3 immune-deviation显示文摘	Miller A Shapiro S Gershtein R	1998	J Neuroimmunol1998，92，：	1
14	Urokinase and tissue plasm inogen aetivatnrs and tbeir inhibitor PAl -in human tumors显示文摘	Gershtein ES Kushlinskii NE	2001	Bull Exp Biol Med2001，131，1：	1
15	Matrix metalloproteinases 2,7, and 9 in tumors and sera of patients with breast cancer显示文摘	Katunina AI Gershtein ES Ermilova VD	2011	Bull Exp Biol Med2011，151，3：	1
16	Plasminogen activators of urokinase and tissue types and their inhibitor(PAI-1) in cytosol fraction in thyroid diseases显示文摘	Gershtein ES Kazantseva IA	2001	Vestn Ross Akad Med Nauk2001，，5：	1
17	Matrix metalloproteinases 2, 7, and 9 in tumors and sera of patients with breast cancer显示文摘	Katunina AI Gershtein ES Ermilova VD	2011	Bull Exp Biol Med2011，151，3：	1
18	Urokinase and tissueplasminogen aetivators and their inhibitor PAI-1 in hu- man tumors显示文摘	Gershtein ES Kushlinskii NE	2001	Bull Exp Bio Med2001，131，1：	1
19	Coupling Combustion Space and Glass Melt Models Improves Predictions显示文摘	Bryan C Hoke J r Vladimir Y Gershtein	1995	The American Ceramic Society Bulletin1995，74，11：	1
20	Phosphatidylinositol 3 -kinase/AKT signalling pathway components in human breast cancer, clinicopathological correlations 显示文摘	Gershtein ES Scherbakov AM Shatskaya VA	2007	Anticancer Res2007，27，4：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示